STAU1 Activators

The chemicals listed above are not direct activators of STAU1 but may influence its activity indirectly through their effects on RNA metabolism, synthesis, stability, or related cellular processes. STAU1's function in RNA metabolism is closely linked to transcriptional and post-transcriptional mechanisms.Compounds like Actinomycin D, α-Amanitin, DRB, CX-5461, and Triptolide affect RNA synthesis by inhibiting various RNA polymerases. These inhibitors can potentially impact the pool of RNA substrates available for STAU1, thereby indirectly influencing its activity.

Leptomycin B, which inhibits nuclear export of RNA, and Flavopiridol, an inhibitor of cyclin-dependent kinases, may alter the nuclear and cytoplasmic dynamics of RNA processing and metabolism, potentially affecting STAU1's role in these processes. Rocaglamide and Rapamycin influence translation initiation and protein synthesis, respectively. By affecting these processes, they might indirectly impact the functional context in which STAU1 operates. Proteasome inhibitors like MG132 and Bortezomib can affect protein turnover, potentially altering the cellular environment and influencing STAU1's activity related to RNA-protein complexes. Lastly, 5-Fluorouracil, known for its impact on RNA metabolism and protein synthesis, might indirectly influence STAU1 function.